Ayr Wellness (AYRWF) Stock Price, News & Analysis

Company Overview

Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

Key Stats

• Today's Range: $0.16 to $0.18
• 50-Day Range: $0.16 to $0.51
• 52-Week Range: $0.15 to $3.46
• Volume: 93,198 shs
• Average Volume: 323,210 shs
• Market Capitalization: $19.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.00
• Consensus Rating: Moderate Buy

Ayr Wellness Stock Analysis - MarketRank™

Ayr Wellness scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Ayr Wellness has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Ayr Wellness has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Ayr Wellness are expected to grow in the coming year, from ($1.31) to ($1.00) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ayr Wellness is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ayr Wellness is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ayr Wellness has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.37% of the float of Ayr Wellness has been sold short.

Short Interest Ratio / Days to Cover

Ayr Wellness has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ayr Wellness has recently increased by 50.16%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ayr Wellness does not currently pay a dividend.

Dividend Growth

Ayr Wellness does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.37% of the float of Ayr Wellness has been sold short.

Short Interest Ratio / Days to Cover

Ayr Wellness has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ayr Wellness has recently increased by 50.16%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.37

News Sentiment

Ayr Wellness has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Ayr Wellness this week, compared to 1 article on an average week.

MarketBeat Follows

3 people have added Ayr Wellness to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ayr Wellness insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.10% of the stock of Ayr Wellness is held by insiders.

Percentage Held by Institutions

Only 0.91% of the stock of Ayr Wellness is held by institutions.

AYRWF Stock Analysis - Frequently Asked Questions

How have AYRWF shares performed this year?

Ayr Wellness' stock was trading at $0.47 on January 1st, 2025. Since then, AYRWF stock has decreased by 63.9% and is now trading at $0.1699.
View the best growth stocks for 2025 here.

How were Ayr Wellness' earnings last quarter?

Ayr Wellness Inc. (OTCMKTS:AYRWF) released its quarterly earnings results on Thursday, March, 6th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.12. The firm had revenue of $113.96 million for the quarter, compared to analyst estimates of $114.10 million. Ayr Wellness had a negative net margin of 48.17% and a negative trailing twelve-month return on equity of 25.30%.

How do I buy shares of Ayr Wellness?

Shares of AYRWF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 3/06/2025
• Today: 3/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AYRWF
• CIK: 1847462
• Web: www.ayrstrategies.com
• Phone: 949-574-3860
• Fax: N/A
• Employees: 2,380
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.00
• High Stock Price Target: $3.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +1,665.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($3.26)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-272,430,000.00
• Net Margins: -48.17%
• Pretax Margin: -38.59%
• Return on Equity: -25.30%
• Return on Assets: -9.94%

Debt

• Debt-to-Equity Ratio: 0.76
• Current Ratio: 1.59
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $463.63 million
• Price / Sales: 0.04
• Cash Flow: $0.02 per share
• Price / Cash Flow: 7.43
• Book Value: $7.39 per share
• Price / Book: 0.02

Miscellaneous

• Outstanding Shares: 116,185,000
• Free Float: 106,774,000
• Market Cap: $19.74 million
• Optionable: Not Optionable
• Beta: 1.70